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Influenza is an important cause of morbidity in HIV positive adults, who may be more susceptible 
and more likely to develop severe disease.(1,2) Annual influenza immunisation is recommended for 
all HIV positive adults in the UK, supported by British HIV Association (BHIVA) guidelines,(1) with 
evidence for reasonably good uptake (3). HIV services do not receive specific funding to provide 
immunisation; and the National Flu Immunisation Programme offers this instead via Primary Care 
and pharmacies.(4) Whether this meets the needs of people living with HIV has not been evaluated.  
To inform the design of services for influenza immunisation we undertook a survey of adults 
attending a metropolitan HIV service during autumn/winter 2015-16. Participants were asked about 
their behaviour regarding influenza immunisation and preferences for services used to obtain this 
(Appendix). We obtained written consent to access clinical records and contact participants later in 
the season to establish whether immunisation had been received. We also documented whether 
participants consented to share details of their HIV status with their GP (General Practitioner), as we 
hypothesised that this might affect their ability to access influenza immunisation. 
253 individuals participated: their median age was 48 years (IQR 41-54); 80% were male; 62% were 
of White, 22% Black and 4% Asian ethnicity. The median blood CD4 count was 627 cells/µL (IQR 434-
873), 96% were using antiretroviral therapy and 76% had an undetectable HIV load.  
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Overall, 212 participants (84%) were aware of the recommendation for annual influenza 
immunisation. 176 individuals (70%) were immunised during the 2015-16 influenza season, 53 (21%) 
were not and in 24 (9%) we had no record of immunisation status as they did not respond to follow-
up. Uptake did not differ significantly by gender, ethnicity, CD4 count or HIV load; those immunised 
were slightly older than those who were not (median 49 compared to 46 years, p=0.005) (Table 1). 
Of those immunised, 90 (51%) had this in their GP practice, 44 (25%) in an HIV service, 15 (9%) in a 
pharmacy and 20 (11%) elsewhere (7 individuals did not specify a location). Those immunised in 
their GP practice or pharmacy were older than those immunised in an HIV care service (mean age 50 
and 49 years for those immunised in GP or pharmacies respectively and 45 years for those 
immunised in HIV care services, p=0.004). Consent to share information between HIV services and 
Primary Care appeared to influence uptake: overall, 180 participants (71%) consented to share 
details of their HIV status with their GP and 49 (19%) did not (for 24 participants this was not 
recorded). Uptake of influenza immunisation was higher in those consenting to data sharing (74% vs 
61%, p=0.05); and individuals immunized in Primary Care were more likely to consent to this than 
those immunized by HIV services (83% vs 67%, p=0.013). 
Our data suggest that HIV positive adults have a reasonable uptake of influenza immunisation and 
around half of these immunisations are provided in Primary Care. Uptake was higher amongst 
people who consented to share details of their HIV status with their GP, and 25% of immunisations 
were provided by the HIV service. This suggests that the current (reasonably good) uptake of 
influenza immunisation relies on significant provision by HIV care providers.  
The 2015 BHIVA guidelines on the immunisation of HIV positive adults suggest that HIV services 
should work in partnership with Primary Care to ensure that patients receive annual immunisation 
(1). Exploring the reasons why individuals do not want to share information between HIV services 
and Primary Care, and creating mechanisms for sharing clinical data (particularly in a way that is 
accessible to service users) could enable better targeting of immunisations for those who do not 
receive these in Primary Care. 
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Promoting Influenza Immunisation In People Attending the ICDC 
Winter 2015-16 
 
 
This questionnaire is about your views on having the influenza immunisation. We will use the 
information obtained to try and improve services both here and at other sites. You do not 
have to complete this questionnaire, and if you do not want to answer any questions just 
leave them blank.  
 
Please note that all information provided will be used for research purposes and to improve 
our patient services. The data will only be accessed by professional staff and will be stored 
securely in accordance with hospital data protection policy.  
 
 
Please complete the following questions, marking yes or no as appropriate and providing 
further details if relevant in the space provided.  
 
 
 
 
Q1. Before today, did you know that the annual flu 
vaccination is recommended for all people with 
HIV infection? 
 
 Yes 
 
 No 
 
Q2.  
A. Have you had, or intend to have, the flu 
vaccination this year? 
 
 
 Yes    
 No 
 I plan to 
B. If yes, where did or will you have it done this 
year? 
 
 
 
 
C. Why did you or will you get it done there? 
(Please record the main reason for choosing to 
have it done there) 
 
 
 
 
 GP Surgery 
 Pharmacy  
 Other (please specify below) 
……………………… 
 
Preferred service  
Prompted to have vaccination 
by staff 
Unsure 
 Other (please specify below) 
……………………… 
 
D. If you have not had the flu vaccination do you 
plan to have it later this year or early next year? 
 
 Yes  
 No 
 
 
 
 
Name: …………………………………………………………….. DOB: ………………….. 
 
Hospital Number: ………………………………………………… Date: ………………….. 
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E.       If not, why is that?  I don’t want it 
 I don’t know where to have it 
done 
 I am allergic to products used 
to make vaccine e.g. egg 
 
Q3. If you do plan to have the flu vaccine this year, we 
recommend that everyone has it at their GP 
surgery. Is that something you feel you can do? 
 
 Yes  
 
 No 
 
 
If yes please go straight to the Closing 
Statement at the end. 
 
Q4.  
A. If you do not feel you can have the vaccine at 
your GP surgery, is there somewhere else you 
can have it? 
 
B. If yes, where? 
 
 
 
 Yes  
 
 
 
 
 No 
 
 
Please specify below: 
…………………………………... 
…………………………………… 
 
If you do not feel you can have the flu vaccine at your GP or elsewhere 
please speak to a Dr/Nurse in ICDC who can discuss your options. 
 
 
Flu Vaccine Administered 
 
 
 Yes  
 
 
 No 
 
 
Signature of staff  
 
………………………………. 
 
 
 
Closing Statement 
Sometimes people can find it helpful to receive a reminder call to help them remember. If you 
plan to have the flu vaccine this year, would you mind being contacted by us in a few weeks 
and at the end of the flu season? It will also provide us with the information we need to 
determine how many people actually have the flu vaccine.
 
Are you happy to be contacted?      
 
 
 Yes 
 
 No 
 
Contact Details 
 
Telephone Number: ……………………………………………………………………………… 
Email: ……………………………………………………………………………………………… 
 
Please sign that you are happy for us to contact you: 
Signature: ………………………………………………………....... Date: …………………… 
 
Thank you for taking the time to complete this questionnaire. 
 
Please turn over. 
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Table 1: Relationship between participant characteristics and uptake of immunisation 
 
 
 Was participant immunized in 2015-16 season?* 
 
p value 
 Yes (n=176) 
 
No (n=53) Unknown 
(n=24) 
Gender□ Female n (row %) 37 (68%) 12 (23%) 5 (9%) 0.92 
Male n (row %) 136 (71%) 38 (20%) 18 (9%) 
Race/ 
ethnic 
origin 
White n (row %) 109 (70%) 34 (22%) 13 (8%) 0.884 
Black n (row %) 35 (64%) 12 (22%) 8(14.5%) 
Other n (row %) 16 (80%) 3 (15%) 1 (5%) 
Mixed n (row %) 6 (86%) 1 (14%) 0 
Not stated n 
(row%) 
10 (67%) 3 (20%) 2 (13%) 
Age, years, median (IQR) 49 (43-55) 46 (39-50) 44 (39-51) 0.005~ 
Blood CD4 count (cells/µL) 
median (IQR)^ 
625 (429-867) 627 (473-881) 636 (459-840) 0.979~ 
Plasma HIV 
load <40 
copies/ml^  
n (row %) 
Yes 143 (71.5%) 40 (20%) 17 (8%) 0.413# 
No 25 (66%) 9 (24%) 4 (10%) 
Consent to 
contact GP 
n (row %) 
Yes 134 (74%) 35 (20%) 11 (6%) 0.05##  
No 30 (61%) 11 (22%) 8 (16%) 
   
** Mann Whitney U test  # Chi Squared test  ‡ Fisher’s exact test ~Kruskal Wallis test 
□ 3 participants did not state their gender 
^blood results available for 240 participants 
## calculation excludes 25 participants with no details regarding consent to GP contact 
